iRhythm Holdings, Inc.

IRTC ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $-381.0K $-13.9M $5.6M $-5.2M $-14.2M $-30.7M $-1.3M $-46.2M
Depreciation & Amortization $5.2M $5.0M $5.2M $5.2M $5.1M $5.2M $5.3M $5.1M
Depreciation — — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation $20.0M $21.5M $21.1M $21.0M $22.8M $23.3M $16.0M $17.2M
Net Cash from Operating Activities $51.1M $-26.2M $26.2M $34.9M $27.7M $-7.9M $19.2M $24.3M
Investing Activities
Capital Expenditures $13.6M $6.9M $11.7M $14.8M $10.4M $9.4M $6.8M $8.8M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-48.6M $30.2M $-48.8M $-89.2M $-100.9M $-38.1M $-122.2M $-55.3M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — $0 $0 $0 $0 $0 $0
Net Cash from Financing Activities $4.1M $149.0K $3.0M $825.0K $7.1M $1.7M $3.0M $-35.0K
Net Change in Cash $6.5M $4.1M $-19.6M $-53.5M $-66.2M $-44.3M $-99.9M $-31.0M
Free Cash Flow $37.5M $-33.1M $14.5M $20.1M $17.3M $-17.3M $12.4M $15.5M
← Newer Page 1 of 6 Older →